ALTERATION OF BINDING OF THE SUPRAVITAL DYE HOECHST 33342 TO HUMAN LEUKEMIC CELLS BY ADRIAMYCINPREISLER HD.1978; CANCER TREATM. REP.; USA; DA. 1978; VOL. 62; NO 9; PP. 1393-1396; BIBL. 3 REF.Article

TREATMENT FAILURE IN AMLPREISLER HD.1982; BLOOD CELLS; ISSN 0340-4684; DEU; DA. 1982; VOL. 8; NO 3; PP. 585-602; BIBL. 19 REF.Article

ACQUISITION OF SELECTED SUBPOPULATIONS OF LEUKEMIC CELLS FOR STUDYPREISLER HD.1980; ANTIBIOT. AND CHEMOTHERAPY; CHE; DA. 1980; VOL. 28; PP. 130-136; (39 P.); BIBL. 32 P.Article

CLONOGENIC POTENTIAL IN VITRO OF PROLIFERATIVE AND QUIESCENT LEUKEMIC CELLSPREISLER HD.1980; LEUKEMIA RES.; GBR; DA. 1980; VOL. 4; NO 2; PP. 245-248; BIBL. 8 REF.Article

EVALUATION OF IN VITRO PREDICTIVE ASSAYS FOR ACUTE MYELOCYTIC LEUKEMIAPREISLER HD.1980; BLUT; ISSN 0006-5242; DEU; DA. 1980; VOL. 41; NO 5; PP. 393-396; BIBL. 6 REF.Article

ESTABLISHMENT OF MURINE MYELOID-LEUKAEMIA CELL LINE IN SUSPENSION CULTUREPREISLER HD.1978; BRIT. J. CANCER; GBR; DA. 1978; VOL. 38; NO 2; PP. 344-349; BIBL. 6 REF.Article

FAILURE OF REMISSION INDUCTION IN ACUTE MYELOCYTIC LEUKEMIAPREISLER HD.1978; MED. PEDIATR. ONCOL.; USA; DA. 1978; VOL. 4; NO 3; PP. 275-276Article

CHARACTERIZATION OF PROLIFERATIVE AND QUIESCENT LEUKEMIC CELLS BY FLOW CYTOMETRYPREISLER HD; DARZYNKIEWICW Z.1981; J. MED. (WESTBURY); ISSN 0025-7850; USA; DA. 1981; VOL. 12; NO 6; PP. 415-425; BIBL. 11 REF.Article

A METHOD FOR OBTAINING HUMAN BONE MARROW SPECIMENS ENRICHED FOR MYELOBLASTS AND PROMYELOCYTESPREISLER HD; EPSTEIN J.1979; J. LAB. CLIN. MED.; USA; DA. 1979; VOL. 94; NO 3; PP. 414-420; BIBL. 10 REF.Article

DIFFERENTIATION OF ERYTHROLEUKEMIC CELLS IN VITRO: IRREVERSIBLE INDUCTION BY DIMETHYL SULFOXIDE (DMSO)PREISLER HD; GILADI M.1975; J. CELL PHYSIOL.; U.S.A.; DA. 1975; VOL. 85; NO 3; PP. 537-546; BIBL. 15 REF.Article

PROTECTED ENVIRONMENT UNITS IN THE TREATMENT OF ACUTE LEUKEMIA.PREISLER HD; BJORNSSON S.1975; SEMINARS IN ONCOL.; U.S.A.; DA. 1975; VOL. 2; NO 4; PP. 369-377; BIBL. 23 REF.Article

ERYTHROPOIETIN RESPONSIVENESS OF DIFFERENTIATING FRIEND LEUKAEMIA CELLS = CAPACITE DE REPONSE A L'ERYTHROPOIETINE DES CELLULES DE LA LEUCEMIE DE FRIEND EN COURS DE DIFFERENCIATIONPREISLER HD; GILADI M.1974; NATURE; G.B.; DA. 1974; VOL. 251; NO 5476; PP. 645-646; BIBL. 15REF.Article

ERYTHROPOIETIN-INDUCED STIMULATION OF HEME SYNTHESIS BY DIMETHYLSULFOXIDE-TREATED FRIEND LEUKEMIC CELLS IN VITRO = STIMULATION INDUITE PAR L'ERYTHROPOIETINE DE LA SYNTHESE DE L'HEME PAR LES CELLULES LEUCEMIQUES FRIEND TRAITEES PAR LE DIMETHYLSULFOXIDE IN VITROPREISLER HD; ZANJANI ED.1974; J. LAB. CLIN. MED.; U.S.A.; DA. 1974; VOL. 84; NO 5; PP. 667-672; BIBL. 11REF.Article

DIFFERENTIATION OF ERYTHROLEUKEMIA CELLS IN VITRO: PROPERTIES OF CHEMICAL INDUCERS.PREISLER HD; LYMAN G.1975; CELL DIFFER.; NETHERL.; DA. 1975; VOL. 4; NO 3; PP. 179-185; BIBL. 11 REF.Article

CORRELATION BETWEEN LEUKEMIC CELL RETENTION OF 1-BETA -D-ARABINOFURANOSYLCYTOSINE 5'-TRIPHOSPHATE AND RESPONSE TO THERAPYRUSTUM YM; PREISLER HD.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 1; PP. 42-49; BIBL. 22 REF.Article

CARCINOMA OF UNKNOWN PRIMARY: NATURAL HISTORY AND RESPONSE TO THERAPYLYMAN GH; PREISLER HD.1978; J. MED.; USA; DA. 1978; VOL. 9; NO 6; PP. 445-459; BIBL. 18 REF.Article

COMPARISON OF AGAR AND METHYLCELLULOSE CULTURE METHODS FOR HUMAN ERYTHROID COLONY FORMATIONKUBOTA K; PREISLER HD.1982; EXP. HEMATOL.; ISSN 0301-472X; USA; DA. 1982; VOL. 10; NO 3; PP. 292-299; BIBL. 14 REF.Article

ANOTHER LOOK AT SURVIVAL CURVES IN CHRONIC MYELOCYTIC LEUKEMIAPREISLER HD; REESE PA.1980; AM. J. HEMATOL.; ISSN 0361-8609; USA; DA. 1980; VOL. 9; NO 1; PP. 123-125; BIBL. 8 REF.Article

PHOSPHOLIPID MEMBRANE STABILIZATION BY DIMETHYLSULFOXIDE AND OTHER INDUCERS OF FRIEND LEUKEMIC CELL DIFFERENTIATION.LYMAN GH; PAPAHADJOPOULOS D; PREISLER HD et al.1976; BIOCHIM. BIOPHYS. ACTA; PAYS-BAS; DA. 1976; VOL. 448; NO 3; PP. 460-473; BIBL. 1 P.Article

ADRIAMYCIN-CYTOSINE ARABINOSIDE THERAPY FOR ADULT ACUTE MYELOCYTIC LEUKEMIA.PREISLER HD; BJORNSSON S; HENDERSON ES et al.1977; CANCER TREATM. REP.; U.S.A.; DA. 1977; VOL. 61; NO 1; PP. 89-92; BIBL. 6 REF.Article

LACK OF ERYTHROID BURST-PROMOTING ACTIVITY IN THE MEDIA CONDITIONED BY ELEVEN HUMAN T CELL LEUKEMIA-LYMPHOMA CELL LINESKUBOTA K; PREISLER HD; MINOWADA J et al.1982; EXP. HEMATOL.; ISSN 0301-472X; USA; DA. 1982; VOL. 10; NO 1; PP. 130-132; BIBL. 4 REF.Article

DNA DAMAGE IN AML CELLS EXPOSED TO ADRIAMYCIN; CORRELATIONS WITH CLINICAL RESPONSE TO THERAPYSCHWARTZ HS; PREISLER HD; KANTER PM et al.1981; LEUK. RES.; ISSN 0145-2126; USA; DA. 1981; VOL. 5; NO 4-5; PP. 363-366; BIBL. 12 REF.Article

MURINE MYELOID LEUKEMIA. I. PATHOPHYSIOLOGY AND DRUG SENSITIVITY.PREISLER HD; BJORNSSON S; MORI M et al.1977; CANCER TREATM. REP.; U.S.A.; DA. 1977; VOL. 61; NO 7; PP. 1259-1268; BIBL. 12 REF.Article

HUMAN T CELL LEUKEMIA-LYMPHOMA CELL LINES AND GRANULOCYTE-MACROPHAGE COLONY STIMULATING ACTIVITYKUBOTA K; PREISLER HD; MINOWADA J et al.1980; IMMUNOL. COMMUN.; ISSN 0090-0877; USA; DA. 1980; VOL. 9; NO 8; PP. 731-734; BIBL. 5 REF.Article

LACK OF EFFECT OF COLONY-STIMULATING ACTIVITY ON HUMAN MYELOID LEUKEMIA CELL LINE (ML-2) CELLSKUBOTA K; PREISLER HD; LOK MS et al.1981; LEUK. RES.; ISSN 0145-2126; USA; DA. 1981; VOL. 5; NO 4-5; PP. 311-320; BIBL. 18 REF.Article